These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 35025923)
1. Identifying barriers to ART initiation and adherence: An exploratory qualitative study on PMTCT in Zambia. Kanguya T; Koyuncu A; Sharma A; Kusanathan T; Mubanga M; Chi BH; Vinikoor MJ; Mubiana-Mbewe M PLoS One; 2022; 17(1):e0262392. PubMed ID: 35025923 [TBL] [Abstract][Full Text] [Related]
2. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study. Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347 [TBL] [Abstract][Full Text] [Related]
3. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study. Chadambuka A; Katirayi L; Muchedzi A; Tumbare E; Musarandega R; Mahomva AI; Woelk G BMC Public Health; 2017 Jul; 18(1):57. PubMed ID: 28743251 [TBL] [Abstract][Full Text] [Related]
4. Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study. Lumbantoruan C; Kermode M; Giyai A; Ang A; Kelaher M PLoS One; 2018; 13(6):e0198329. PubMed ID: 29912960 [TBL] [Abstract][Full Text] [Related]
5. What influences uptake and early adherence to Option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in Central Uganda? A mixed methods study. Mukose AD; Bastiaens H; Makumbi F; Buregyeya E; Naigino R; Musinguzi J; Van Geertruyden JP; Wanyenze RK PLoS One; 2021; 16(5):e0251181. PubMed ID: 33951109 [TBL] [Abstract][Full Text] [Related]
6. 'I wanted to safeguard the baby': a qualitative study to understand the experiences of Option B+ for pregnant women and the potential implications for 'test-and-treat' in four sub-Saharan African settings. McLean E; Renju J; Wamoyi J; Bukenya D; Ddaaki W; Church K; Zaba B; Wringe A Sex Transm Infect; 2017 Jul; 93(Suppl 3):. PubMed ID: 28736391 [TBL] [Abstract][Full Text] [Related]
7. Development and validation of a novel scale for antiretroviral therapy readiness among pregnant women in urban Zambia with newly diagnosed HIV infection. Mubiana-Mbewe M; Bosomprah S; Saroj RK; Kadota J; Koyuncu A; Thankian K; Vinikoor MJ AIDS Res Ther; 2023 Apr; 20(1):21. PubMed ID: 37024961 [TBL] [Abstract][Full Text] [Related]
8. Lessons learned from the PMTCT program in Swaziland: challenges with accepting lifelong ART for pregnant and lactating women - a qualitative study. Katirayi L; Chouraya C; Kudiabor K; Mahdi MA; Kieffer MP; Moland KM; Tylleskar T BMC Public Health; 2016 Oct; 16(1):1119. PubMed ID: 27776495 [TBL] [Abstract][Full Text] [Related]
9. Understanding Antiretroviral Treatment Adherence Among HIV-Positive Women at Four Postpartum Time Intervals: Qualitative Results from the Kabeho Study in Rwanda. Gill MM; Umutoni A; Hoffman HJ; Ndatimana D; Ndayisaba GF; Kibitenga S; Mugwaneza P; Asiimwe A; Bobrow EA AIDS Patient Care STDS; 2017 Apr; 31(4):153-166. PubMed ID: 28358624 [TBL] [Abstract][Full Text] [Related]
10. Acceptability of community-based mentor mothers to support HIV-positive pregnant women on antiretroviral treatment in western Kenya: a qualitative study. Wanga I; Helova A; Abuogi LL; Bukusi EA; Nalwa W; Akama E; Odeny TA; Turan JM; Onono M BMC Pregnancy Childbirth; 2019 Aug; 19(1):288. PubMed ID: 31409297 [TBL] [Abstract][Full Text] [Related]
11. Impact of inter-partner HIV disclosure patterns in Malawi's PMTCT program: A mixed-method study. van Lettow M; Cataldo F; Landes M; Kasende F; Nkhoma P; van Oosterhout JJ; Kim E; Schouten E; Nkhoma E; Nyirenda R; Tippett Barr BA PLoS One; 2019; 14(7):e0219967. PubMed ID: 31348782 [TBL] [Abstract][Full Text] [Related]
12. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review. Omonaiye O; Kusljic S; Nicholson P; Manias E BMC Public Health; 2018 Jun; 18(1):805. PubMed ID: 29945601 [TBL] [Abstract][Full Text] [Related]
13. The Video intervention to Inspire Treatment Adherence for Life (VITAL Start): protocol for a multisite randomized controlled trial of a brief video-based intervention to improve antiretroviral adherence and retention among HIV-infected pregnant women in Malawi. Kim MH; Tembo TA; Mazenga A; Yu X; Myer L; Sabelli R; Flick R; Hartig M; Wetzel E; Simon K; Ahmed S; Nyirenda R; Kazembe PN; Mphande M; Mkandawire A; Chitani MJ; Markham C; Ciaranello A; Abrams EJ Trials; 2020 Feb; 21(1):207. PubMed ID: 32075677 [TBL] [Abstract][Full Text] [Related]
14. The Lived Experience of Antiretroviral Therapy for Pregnant Women: Antiretroviral Therapy Adherence as a Balancing Act. Shore JE; Paun O; Vonderheid SC J Assoc Nurses AIDS Care; 2020; 31(4):448-456. PubMed ID: 31094866 [TBL] [Abstract][Full Text] [Related]
15. 'I fear my partner will abandon me': the intersection of late initiation of antenatal care in pregnancy and poor ART adherence among women living with HIV in South Africa and Uganda. Alhassan Y; Twimukye A; Malaba T; Myer L; Waitt C; Lamorde M; Colbers A; Reynolds H; Khoo S; Taegtmeyer M BMC Pregnancy Childbirth; 2022 Jul; 22(1):566. PubMed ID: 35840939 [TBL] [Abstract][Full Text] [Related]
16. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study. Katirayi L; Namadingo H; Phiri M; Bobrow EA; Ahimbisibwe A; Berhan AY; Buono N; Moland KM; Tylleskär T J Int AIDS Soc; 2016; 19(1):20919. PubMed ID: 27312984 [TBL] [Abstract][Full Text] [Related]
17. Facilitators and Barriers to Adherence to Antiretroviral Therapy and Retention in Care Among Adolescents Living with HIV/AIDS in Zambia: A Mixed Methods Study. Mesic A; Halim N; MacLeod W; Haker C; Mwansa M; Biemba G AIDS Behav; 2019 Sep; 23(9):2618-2628. PubMed ID: 31093820 [TBL] [Abstract][Full Text] [Related]
18. Role of male partner involvement in ART retention and adherence in Malawi's Option B+ program. Wesevich A; Mtande T; Saidi F; Cromwell E; Tweya H; Hosseinipour MC; Hoffman I; Miller WC; Rosenberg NE AIDS Care; 2017 Nov; 29(11):1417-1425. PubMed ID: 28355926 [TBL] [Abstract][Full Text] [Related]
19. Echoes of old HIV paradigms: reassessing the problem of engaging men in HIV testing and treatment through women's perspectives. Katirayi L; Chadambuka A; Muchedzi A; Ahimbisibwe A; Musarandega R; Woelk G; Tylleskar T; Moland KM Reprod Health; 2017 Oct; 14(1):124. PubMed ID: 28982365 [TBL] [Abstract][Full Text] [Related]
20. Beyond "Option B+": Understanding Antiretroviral Therapy (ART) Adherence, Retention in Care and Engagement in ART Services Among Pregnant and Postpartum Women Initiating Therapy in Sub-Saharan Africa. Myer L; Phillips TK J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S115-S122. PubMed ID: 28498180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]